Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate subjects in an prospective observational study
Subjects will be administered scientifically validated questionnaires
Determine the affect of the Portable Oxygen Concentrator (POC) on improvements in:
Exercise capability, dyspnea and quality of life as primary endpoints
Utilize:
The secondary endpoints will be:
Evaluate subjects in an prospective observational study in which subjects will be screened and administered scientifically validated questionnaires at study entry and during the observation period at specified intervals to determine the affect of the Portable Oxygen Concentrator on improvements in exercise capability, dyspnea and quality of life as primary endpoints, utilizing the Baseline Dyspnea Index (BDI), Transitional Dyspnea Index (TDI), the Chronic Respiratory Disease Questionnaire (CRQ) and six minute walk test (6MWT). The secondary endpoints will be rate of exacerbations, sleep quality (reported as number of hours sleep improvement; utilize Epworth Sleepiness Scale [ESS]), and health care utilization (emergency room encounters, hospital admissions).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| chronic obstructive pulmonary disease |
|
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Functional Capacity | Change in functional capability, dyspnea - BDI/TDI • Change in exercise capability - 6MWT | 6 months |
| Quality of Life Using Chronic Respiratory Disease Questionnaire | Quality of life - Chronic Respiratory Disease Questionnaire | Measure Dyspnea at baseline upon study entry and change from baseline every two weeks up to three months; Numerical, 7-point modified Likert Scale; Total score and subscores on categories; higher scores indicate better health-related quality of life |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
COPD Patients prescreened and selected by their primary care physician or pulmonologist
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Isabel Pereira, MD | Tri-City Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tri-City Pulmonary Medical Group | Oceanside | California | 92054 | United States | ||
| Cardinal Medical Group |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
| Vista |
| California |
| 92083 |
| United States |
| Pathway Medical Group | Westminster | California | 92683 | United States |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |